ARCHIVES

In Congress: Time Running out On Effort To Double Market Exclusivity Term

This article is from The Cancer Letter archive.

Vol. 23 No. 43 | November 7, 1997

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI

March 26, 2004

No Longer A Hands-Off Shareholder, Roche Seeks Full Control Of Genentech.

July 25, 2008

Harold Freeman To Direct NCI Center To Reduce Cancer Health Disparities.

September 15, 2000

FDA Approves Tamoxifen For DCIS Folowing Breast Surgery And Radiation.

July 28, 2000

NCI Staff Recommends Moving Cooperative Groups Into DCT, Increase Funding, Switch Emphasis

July 4, 1975

In Brief: ESMO Names Annual Award Winners

October 10, 2014